Pierre Beaurang - Chief Business Officer at Nurix Therapeutics, Inc.

Insider Transactions and Holdings

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class
Common Stock	117K	$1.17M	$10.00	Aug 10, 2021	By Trust
Common Stock	4.33K	$43.3K	$10.00	Aug 10, 2021	Direct
Employee Stock Option (right to buy)	6.56K			Aug 10, 2021	Direct	Common Stock

Showing 1 to 3 of 3 entries

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.